Moreover, high Hsp90 expression has been associated with decreased survival in breast cancer (26) whilst its inhibition can suppress growth and promote apoptosis in breast cancer cells, suggesting that Hsp90 could act as both a biomarker and a therapeutic target for breast cancer (27). Here, HSP90AB1 is linked to breast carcinoma.